Drug intelligence / Profile preview

3C066-DM1

Development stage
Unknown
Lead developer
Kyowa Kirin
Modality
Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**3C066-DM1** is an experimental, fully human anti-epithelial cell adhesion molecule antibody-drug conjugate generated by chemically coupling the 3C066 anti-EpCAM monoclonal antibody to the maytansinoid microtubule inhibitor DM1 using affinity peptide-based chemical conjugation. The parental antibody recognizes the EpRE region of EpCAM, and the conjugate showed significant in-vitro cytotoxicity against EpCAM-expressing HCT116 human colon cancer cells. It is a published preclinical research ADC rather than an approved or clinically registered therapeutic product. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10015092/))

02

Targets

TUBB (Tubulin (alpha and beta subunits))EPCAM (Epithelial cell adhesion molecule)

Beyond the preview

Go deeper on 3C066-DM1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3C066-DM1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call